We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Clinical trial reports maintenance of clinical response in cutaneous lupus erythematosus patients through altered dosing of anifrolumab, indicating potential treatment flexibility.
No takes yet. Share an insight, caveat, or question.
Julie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: